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Abstract
OBJECTIVES: Lobar lung transplantation is an option that provides the possibility of transplanting an urgent listed recipient of small size
with a size-mismatched donor lung by surgically reducing the size of the donor lung. We report our short- and long-term results with
bilateral lobar lung transplantation (BLLT) and compare it with the long-term outcomes of our cohort.
METHODS: Retrospective analyses of 75 lung transplant recipients who received downsized lungs with a special focus on 23 recipients
with BLLT performed since January 2000. Postoperative surgical complications, lung function tests, late complications and survival were
analyzed. The decision to perform lobar transplantation was considered during allocation and ﬁnally decided prior to implantation.
RESULTS: Cystic ﬁbrosis was the most common indication (43.5%) followed by pulmonary ﬁbrosis (35%). Median age at transplantation
was 41 (range 13–66) years. Fifteen were females. Nineteen of the transplantations (83%) were done with extracorporeal membrane
oxygenation (ECMO) support; 3 of them were already on ECMO prior to transplantation. There was no 30-day or in-hospital mortality.
No bronchial complications occurred. The most common early complication was haematothorax (39%), which required surgical inter-
vention. The rate of postoperative atrial arrhythmias was 30%. Forced expiratory volumes in 1 s (% predicted) at 1 and 2 years were
76 ± 23 and 76 ± 22, respectively (mean ± standard deviation). By 2-year follow-up, bronchiolitis obliterans syndrome was documented
in 3 patients with a median follow-up of 1457 days. Overall survivals at 1 and 5 years were 82 ± 8 and 64 ± 11%, respectively and were
comparable with those of 219 other recipients who received bilateral lung transplantation during the same period (log rank test,
P = 0.56).
CONCLUSIONS: This study demonstrates that BLLT has short- and long-term outcomes comparable with those of standard bilateral
lung transplantation. The limitation of lung transplantation due to size-mismatch, particularly in smaller recipients, could be overcome
by utilizing lobar lung transplantation.
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INTRODUCTION
In spite of the overall increasing survival rates in lung transplant-
ation, there is an ongoing limitation of suitable donor organs as
the availability of cadaveric donor lungs has failed to increase
with the rise in numbers of transplant candidates. Due to the in-
creasing scarcity of donors, in particular for smaller and urgent
recipients, advanced operative strategies have been developed
[1–9]. Peripheral segmental resection is the most common
method for downsizing, whereas lobar and split lung transplants
are other options performed to downsize donor lungs in order
to achieve an adequate match [1–8]. Oversized lung grafts can
potentially lead to atelectasis and impaired airway clearance due
to bronchial anatomy distortion. Undersized grafts cause lung
hyperexpansion and might limit exercise tolerance due to
haemodynamic compromise [10]. In 1994, Bisson et al. [11]
reported the ﬁrst cadaveric bilateral lobar lung transplantation
(BLLT) in 2 recipients with cystic ﬁbrosis. Later, other centres
reported their experience with size-reduced lung transplantation,
describing the short-term outcomes [1–5]. In these series, func-
tional outcomes and overall survival rates were comparable with
standard lung transplantation; however, long-term follow-up was
limited. Recently, the Melbourne Group reported their long-
term lung function and survival in cadaveric lobar lung
transplantation [7, 8]. In this study, we report the long-term out-
comes for recipients who have undergone BLLT at our institution
since 2000.
MATERIALS AND METHODS
Since the beginning of our lung transplant program in 1992 to
the end of December 2011, we have performed 342 lung
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transplants. There are 308 bilateral sequential, 33 single and 1
heart lung transplants that have been performed.
Since January 2000, 75 recipients received downsized lungs.
Of these, 23 patients underwent BLLT with anatomical lobectomy
(9% of the total lung transplantations in the study period). These
recipients are the main focus of this study. The recipients who
underwent bilateral standard lung transplantation without any
size reduction constituted the control group only for the com-
parison of the overall survival with those who underwent BLLT.
Data were prospectively collected on all recipients and retro-
spectively analyzed. Censor date for survival was taken on 23
January 2012. The median follow-up was 40.8 (range 1.1 to
137.3) months. All patients consented to the use of lobar
transplants.
Indications for BLLT were cystic ﬁbrosis (n = 10), pulmonary ﬁ-
brosis (n = 8), emphysema (n = 3), primary pulmonary hyperten-
sion, progressive systemic sclerosis and bronchiolitis (for each
n = 1). Sixteen patients were female, with a median age of 41
(range 13–66) years. At our centre, we follow the recently pub-
lished guidelines regarding referral and selection of lung trans-
plant candidates [12]. Organ preservation was performed with
Perfadex® (Vitrolife, Gothenburg, Sweden). Before antegrade
ﬂush, 500 µg of prostaglandin E1 (Prostin VR, Upjohn, Puurs,
Belgium) was injected into the pulmonary artery in all cases. We
also perform retrograde ﬂush with Perfadex® at the time of the
back-table preparation.
The decision to perform size-reduced lung transplantation was
made in the operating theatre during implantation based on a
visual assessment of the size discrepancy after the patient having
been identiﬁed as potentially needing a lobar transplantation,
based on donor to recipient (D–R) height discrepancy. Our
standard technique for BLLT has been to perform the surgery
through two separate anterolateral thoracotomies through the
fourth or ﬁfth intercostal space.
According to our standard protocol, patients received induc-
tion therapy (antithymocyte globulin or basiliximab) and triple
immunosuppressive therapy including cyclosporine, mycophe-
nolate mofetil and prednisone. Anti-infective prophylaxis was
used according to our centre’s protocol described elsewhere
[13]. Post-transplant management at our centre includes routine
surveillance bronchoscopies with transbronchial biopsies and
broncho-alveolar lavage during the ﬁrst 6 months after trans-
plant, serial laboratory lung function tests and regular outpatient
clinic follow-up visits.
Predicted donor total lung capacity (litres) was measured as:
for male patients = 7.99 × height in meters − 7.08 and for female
patients = 6.6 × height in meters − 5.79 [14]. These were calculated
and corrected for size-reduced total lung capacity (sr-TLC) with
respect to size reduction. We calculated sr-TLC by using the
following equation: sr-TLC = donor TLC × (1 − S × 0.0526), with
S = number of resected segments [15].
Statistical analysis
Descriptive statistics was used, and data are expressed as mean ±
standard deviation. The statistical analysis was performed with
SPSS 20 for windows. Actuarial survival rates were calculated by
the Kaplan–Meier method and compared with the log-rank test.
The hazard ratio was calculated. For correlation analysis, the
Pearson Correlation test was used. P < 0.05 was considered
signiﬁcant.
Surgical procedure
On the right side, in order to transplant the middle and lower
lobes, an upper lobectomy was performed. The major ﬁssure
was entered, and the interlobar pulmonary artery was prepared.
The upper lobe vein was dissected, tied and transected. The
atrial cuff receiving both the right superior and inferior veins was
preserved. The upper part of the major ﬁssure between the
upper and lower lobes and the minor ﬁssure between the upper
and middle lobes was separated with the use of a stapler. The
branches of the pulmonary artery to the upper lobe were dis-
sected, tied and divided. Transection of the bronchus was done
at the distal part of the intermediate bronchus, just one ring
above the middle lobe and apical segment bronchus of the
lower lobe, taking great care to protect the peribronchial con-
nective tissue (Fig. 1).
To implant only the right upper lobe, the right lower and
middle lobes were resected. The major ﬁssure was entered, and
the interlobar pulmonary artery was dissected. The middle lobe
artery was identiﬁed, tied and transected. The interlobar pul-
monary artery was tied, preserving the posterior ascending
artery to the upper lobe, and transected. The lower and the
middle veins were dissected, tied and transected. The atrial cuff
was preserved. The upper lobe bronchus was transected just at
the level of its separation from the main bronchus. To perform
upper and lower lobes, the middle lobe was resected. The
middle lobe vein and artery were dissected, tied and transected.
In case of parenchymal bridge between upper and middle lobe,
it was separated with a stapler. The middle lobe bronchus was
transected with a stapler. In this situation, before implantation of
the right upper and lower lobes, the main bronchus was cut just
one ring above the right upper lobe bronchus.
Figure 1: Bronchus transection lines during lobar transplantation. For implant-
ation of the right middle and lower lobes, the transection of the bronchus
was done at the distal part of the intermediate bronchus, just one ring above
the middle lobe and apical segment bronchus of the lower lobe. For right
upper lobe implantation, the upper lobe bronchus was transected just at the
level of its separation from the main bronchus. For implantation of right
upper and lower lobes, the main bronchus was cut just one ring above the
right upper lobe bronchus. Left upper lobe implantation, immediately before
implantation the upper lobe bronchus was divided at the level of its connec-
tion with the main bronchus. Left lower lobe implantation, the left lower lobe
bronchus was transected just at the level of the lobar bifurcation, allowing the
anastomosis to be performed preserving the bronchus of the apical segment
of the lower lobe.
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On the left side, to implant the left upper lobe, a left lower
lobectomy was performed. The ﬁssure was entered. The bridge
between the upper and lower lobes was separated using a
stapler. The interlobar pulmonary artery was dissected, tied dis-
tally to the lingula artery and transected. The lower lobe apical
segment artery was dissected, tied and transected. The lower
lobe vein was prepared, tied and transected. The atrial cuff was
divided, leaving enough cuff tissue around the superior pulmon-
ary vein. Just before implantation, the upper lobe bronchus was
divided just at the level of its connection with the main
bronchus.
To perform left lower lobe transplantation, an upper lobec-
tomy was performed. The ﬁssure was prepared. The bridge
between the upper and lower lobes was separated using a
stapler. The interlobar pulmonary artery was dissected. The
lingula artery and the branches to the upper lobe were tied and
divided. The superior pulmonary vein was tied and divided. The
atrial cuff was preserved. The left lower lobe bronchus was trans-
ected just at the level of the lobar bifurcation, allowing the anas-
tomosis to be performed, preserving the bronchus of the apical
segment of the lower lobe.
First, the bronchial anastomosis was carried out. All dissection
close to the bronchus was done using the ‘minimal’ or ‘no touch’
technique in order to keep the peribronchial tissue intact [16].
A continuous suture of the membranous wall (polydioxanone
suture [PDS], 4/0) and end-to-end anastomosis with interrupted
single sutures (PDS, 4/0) of the cartilaginous part were performed.
Venous (atrium) and pulmonary artery anastomoses were then
performed. Deairing was performed via the antegrade way.
RESULTS
The median waiting list time was 150 (range 15–1063) days. The
mean ischaemic time for the right side was 256.4 ± 88.8 min and
for the left side was 332.5 ± 97.9 min. The median operation
time was 492 (range 275–970) min. The median mechanical ven-
tilation time was 1 (range 1–52) days. The median intensive care
unit length of stay was 14 (range 2–56) days.
The donor age was 38.5 ± 13.9 years. Twenty-one of the
donors were male. The major cause of donor death was intracra-
nial bleeding (n = 17). The donor’s partial oxygen pressure at the
time of retrieval was 40.2 ± 16.2 kPa. Donor and recipient charac-
teristics are shown in Table 1.
In 12 transplants, we performed middle and left upper lobec-
tomy, which were the most common types of lobectomies
performed on the back table. Right upper and left lower lobec-
tomies were performed in 4 cases. Right upper, middle and left
upper lobectomies were performed in 3 transplants. The other
lobectomy combinations were: left upper, middle and right
upper lobectomy (n = 1); middle, right lower and left lower lob-
ectomy (n = 1); right upper and left lower lobectomy (n = 1); right
upper, middle and left upper lobectomy (n = 1).
Nineteen (83%) of the transplantations were performed with
extracorporeal membrane oxygenation (ECMO) support. Three
recipients were on ECMO preoperatively and one had tracheos-
tomy. Two of the 3 patients who were on ECMO preoperatively
required postoperative ECMO and 2 recipients who had intrao-
perative ECMO also required ECMO postoperatively.
Atrial ﬁbrillation (30%) and haemothorax requiring reoperation
(39%) were the most common early postoperative complications.
In 14 recipients, we performed tracheotomy. Primary graft
dysfunction developed in 3 patients. One patient developed oe-
sophageal perforation and intracranial bleeding. She survived
both complications. One recipient was reoperated on post-
operative day 3 due to venous anastomotic stricture. We did not
observe any bronchial complication. Late complications were
rare. In 2 patients, we observed lymphocel at the site of inguinal
ECMO cannulation. Pericostal suture insufﬁciency (n = 1), spino-
cellular carcinoma (n = 3), vulva carcinoma (n = 1) and mechanic
ileus (laparotomy, laparoscopy) (n = 2) were the other late
complications.
Lung function testing at 3, 6, 12, 24 and 36 months revealed %
predicted forced expiratory volume in 1 s (FEV1; mean ± SD) of
74.5 ± 23.8, 75.3 ± 20.7, 76.8 ± 23.5, 76.5 ± 22 and 71.3 ± 18.5, re-
spectively (Fig. 2).
There was a statistically signiﬁcant correlation between the
donor sr-TLC (estimated TLC from donor adjusted to the
number of segments resected) and the % predicted recipient
FEV1 at 3 months (Pearson’s correlation coefﬁcient (r) = 0.485,
P = 0.04).
Postoperative % TLC, % predicted FEV1 at 3, 6 and 12 months
signiﬁcantly correlated with donor–recipient (D–R) height
Table 1: Recipient and donor characteristics
Recipient height (cm) 159.5 ± 8.8
Recipient weight (kg) 56.3 ± 17.2
Donor height(cm) 180 ± 8.2
Donor weight (kg) 79.4 ± 15.9
D–R height difference (cm) 20.5 ± 13.6
D–R weight difference (kg) 23.1 ± 23.9
Donor-predicted TLC (l) 7.2 ± 0.8
sr-TLC (l) 4.4 ± 0.7
Recipient preoperative actual TLC (l) 3.8 ± 1.4
Recipient preoperative predicted TLC (%) 82.4 ± 31.8
Recipient preoperative FEV1 (l) 1.2 ± 0.75
Recipient preoperative predicted FEV1 (%) 40.7 ± 23.3
Recipient postoperative TLC (l) 3.6 ± 0.5
Recipient postoperative predicted TLC (%) 71.8 ± 18.6
D–R TLC difference (l) 3.2 ± 1.4
Number of resected segments (median) 6 (range 6–12)
Data are expressed as mean ± standard deviation. D–R: donor to
recipient; TLC: total lung capacity; sr-TLC: donor total lung capacity
corrected for size reduction; FEV1: forced expiratory volume in 1 s.
Figure 2: The line graph shows the long-term lung function evolution for the
cohort during 36 months following the BLLT. Forced expiratory volume in 1 s
% predicted (FEV1%) improved during the 2-year period. Error bars show
standard deviation.
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difference (r = 0.564, P = 0.02; r = 0.479, P = 0.04; r = 0.531,
P = 0.01; r = 0.611, P = 0.007).
Donor-predicted TLC also signiﬁcantly correlated with D–R
height (r = 0.755, P = 0.0001) and weight (r = 0.587, P = 0.003)
difference.
sr-TLC correlated with the number of transplanted segments
(r = 0.659, P = 0.001). There was a signiﬁcant negative correlation
between the number of transplanted segments and D–R height
and weight difference (r = −0.568, P = 0.005).
There was no 30-day mortality. Early mortality within the 90
days was 8.6% (n = 2). The causes of these deaths were sepsis
(n = 1) and multiorgan failure (n = 1). One of them was on ECMO
4 weeks prior to transplantation and the other patient had multi-
resistant Pseudomonas aeruginosa. The causes of death among
the other 6 patients who died to date were multiorgan failure
and cytomegalovirus disease (n = 1), organizing pneumonia
(n = 1), respiratory failure (n = 3) and unknown (n = 1).
By 2-year follow-up, bronchiolitis obliterans syndrome (BOS) was
documented in 3 patients with a median follow-up of 1457 (range
113–4178) days. BOS Stage 3 developed in 2 and BOS Stage 2 in 1
recipient. In the ﬁrst 2 recipients, the percent fall in best FEV1 was
30.4 and 41.2, respectively. In the one with BOS Stage 2, the
percent fall in best FEV1 was 59.1. By 3-year follow-up, 1 recipient
developed BOS Grade 1 and another 2, potential BOS leading to
FEV1 values of 70.2, 82.4 and 88.6% of their respective previous
best FEV1 values determined according to standard deﬁnitions.
Survival analysis showed no signiﬁcant difference between
BLLT and standard bilateral lung transplantation (hazard
ratio = 0.808, 95% conﬁdence interval 0.387–1.686; Fig. 3). The
estimated 1- and 5-year survival rates in BLLT were 82 ± 8 and
64 ± 11% compared with 88 ± 2 and 69 ± 3% in bilateral lung
transplantation (BLT) (P = 0.56).
DISCUSSION
Reducing the size of an oversized lung graft either by non-
anatomical resection or by lobectomy is one of the methods to
increase the donor pool, particularly for small recipients in case
of a donor–recipient size mismatch. However, it is not routinely
performed in many transplant centres. Optimal size matching is
important because of the potential problems that might occur
following the use of oversized grafts [1–4, 7, 8]. Previous experi-
mental studies have shown the adverse effects of oversized grafts
on chest mechanics, atelectasis of the graft and pulmonary
haemodynamics [10]. In a canine model of bilateral living donor
lobar lung transplantation, both pulmonary vascular resistance
and peak airway pressure were signiﬁcantly increased after the
chest closure due to the overcrowding phenomena in animal
lung grafts that did not undergo size reduction, whereas little
change was observed in those that underwent size reduction [10].
In 1994, Bisson et al. [11] reported the ﬁrst lobar lung trans-
plantation in 2 cystic ﬁbrosis patients. They transplanted left
lower lobe and right lower and middle lobes. In 1997, Couetil
et al. [5] published their series of 7 cases with bipartitioning of
the left lung. They reported a median survival of 19 months with
good exercise tolerance and lung function. Aigner et al. [17] from
the Vienna Group published the largest series in 2004 with 18
lobar lung transplantations. They reported 80% 3-month survival
with only one bronchial complication seen in the lobar
Figure 3: Actuarial survival rates calculated by the Kaplan–Meier method and compared using the log-rank test did not show any difference between BLLT (n = 23)
and standard bilateral lung transplantation (n = 219), P = 0.56.
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transplant group. Similar short-term results following lobar trans-
plantation have been reported [4, 9]. The Melbourne Group re-
cently published their long-term results in lobar lung
transplantation [7, 8]. In their ﬁrst publication, they reported on 5
bilateral, and in their most recent report, they extended their
series to 23 lobar transplants in which 13 underwent BLLT. They
reported similar overall survival rates in the lobar lung transplant
group compared with the standard lung transplant group [8].
Our results presented here support the similar overall survival
rates.
For optimal size matching, different methods have been pro-
posed, such as donor–recipient difference or ratio in body
weight and height [1–3]. In addition, chest circumference and
chest X-ray vertical and transverse dimensions have been used
[1]. The use of donor and recipient total lung capacity for
optimal size matching has also been reported [2–5, 17]. Small dif-
ferences in the lung graft size can be managed by stapler resec-
tion or peripheral non-anatomical wedge resection. Generally,
on the right-side middle lobe and on the left side, the lingula
are the preferred lobes for resection [2]. This technique of size
reduction has been reported to lead to 10–15% downsizing
not only in height but also in the anterior–posterior diameter
since the upper lobe rotates towards the lower lobe [17]. We use
D–R height difference to identify a possible size reduction. In
our series, the D–R height difference ranged from 0 to 47 cm
(mean 20.5 cm). The recipient with 0 cm height difference had
idiopathic pulmonary ﬁbrosis (IPF) and he was on ECMO for 4
weeks prior to transplantation. If we consider this group of
patients with IPF, due to small chest cavity, enlarged heart on
the left side and increased mediastinal fat amount, the need for
size-reduced lung transplantation can be anticipated even with a
lower D–R height discrepancy.
The use of cardiopulmonary bypass (CPB) or ECMO has been
advocated by some centres in order to prevent reperfusion
injury of the ﬁrst transplanted lobe [8, 9, 17]. The utilization rate
of CPB or ECMO of the recent series varied between 56 and
100% [8, 9, 17]. In our series, ECMO was used intraoperatively in
83% (n = 19), whereby 3 patients were already on ECMO prior to
transplantation. To protect the ﬁrst transplanted lobe, especially
if the pulmonary artery pressure is high or in case of marginal
donor lung, we do not hesitate to perform the operation with
ECMO. In addition to this concept, our recipient population
characteristics (IPF, n = 8) also explain the high rate of ECMO use
during transplantation.
Lobectomy for size reduction can be performed on the back
table or after implantation. The advantages of back-table lobec-
tomy are saving time, because it can be performed simultan-
eously with recipient preparation for transplantation by a
separate surgeon, and by preventing a big size mismatch the
view of the hilum is not impaired [8]. On the other hand, it can
be technically difﬁcult to perform the back-table lobectomy as
the vessels are not distended by blood, which makes the dissec-
tion more difﬁcult [8]. On the other hand, lobectomy following
engraftment may be difﬁcult to perform due to the large size of
the lung within a small chest cavity [8]. Manipulation of the re-
cently perfused lung with reperfusion injury is another disadvan-
tage of postimplantation lobectomy as it may cause more injury
to the transplanted lung. As previously reported by others [6–9,
17], we also perform donor lung lobectomy on the back
table immediately before the implantation because of the
advantages mentioned above.
Which lobes should be resected or which lobes should be
implanted may differ depending on patient characteristics. This
depends on the disparity of the size mismatch, the condition of
the graft and the preference and experience of the implantation
team. Upper lobectomy is technically easier, because the
remaining lower lobe results in a conﬁguration that is similar to
the whole lung [9, 17]. However, if the lower lobes are consoli-
dated or contused, it is preferable to perform lower lobectomy
on both sides. In our series, 83% of the recipients had upper
lobectomies performed, and implantation of the remaining
lungs was performed without any problem.
The rate of bronchial anastomotic complications was 5.5 and
13% in the two recent series reporting lobar lung transplantation
[8, 17]. In our series, we have not observed any bronchial anasto-
motic complications. Bronchial ischaemia is reported to be a sig-
niﬁcant risk factor for the development of airway complications
[16]. The viability of the donor bronchus is initially dependent
upon retrograde low-pressure collaterals derived from the pul-
monary artery since bronchial arterial circulation is lost during
the harvest of the donor lungs [18]. To prevent ischaemic bron-
chial complications, we transect the bronchus as distally as pos-
sible, which reduces the part of donor bronchus at risk for
ischaemia (Fig. 1). Additionally, we do not grasp the bronchus
with the forceps during implantation, thus preventing tissue
damage [6, 16].
The survival rate of our BLLT was comparable with that of
standard BLT. Although the estimated survival rate was better for
BLT at 1 and 5 years, the difference was not statistically signiﬁ-
cant. The reasons for this observation may be related to the con-
dition of some recipients prior to transplantation: We had 3
patients on ECMO and 1 on ventilator prior to transplantation,
as well as a large proportion of other very sick recipients, espe-
cially with IPF diagnosis, frequently with a rapid deterioration
immediately prior to transplantation so they were unable to wait
for a size-matched or an ideal organ.
In conclusion, we have shown that BLLT has short- and long-
term outcomes comparable with those of standard bilateral lung
transplantation. The limitation of lung transplantation due to
size-mismatch, particularly in smaller adults and paediatric
recipients, could be overcome by utilizing lobar lung
transplantation.
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Potential lung transplant recipients of small stature and those
with reduced pleural space, for example, with pulmonary ﬁbro-
sis, typically have a longer waiting time for donor lungs of suit-
able size. Cadaveric lobar lung transplantation (CLLT) has been
increasingly employed to expand the donor pool for such
patients who might not survive the lengthy wait for a whole lung
donor. Subsequent to the initial reports of successful lobar trans-
plantation by Bisson et al. [1, 2] two decades ago, centres includ-
ing Vienna [3], Spain [4], France [5] and more recently Australia
[6] have reported their experience. The present series from the
University Hospital, Zurich [7] is a valuable addition to the exist-
ing literature. These studies suggest that CLLT has a long-term
survival comparable with lung transplantation. We have select-
ively performed more than 20 CLLT at our institution in the
adult lung transplant programme and have also found favourable
results (unpublished data).
Strategies to downsize donor lungs in the presence of donor–
recipient (D–R) size discordance include either parenchymal
wedge resection or anatomical lobectomy. Lobectomy can
either be performed before (back table) or after implantation.
CLLT, in the true sense, refers to the strategy of back-table lobec-
tomy and implantation of a single lobe of the donor left lung or
one or two lobes of the donor right lung. The initial reported ex-
perience of CLLT was described using the split donor left lung as
it was felt to be technically easier. The donor left lower lobe was
placed in the recipient’s left side and donor left upper lobe in
the recipient’s right side. Ideally, in such a situation, the right
lung can go to a different recipient. However, this requires tre-
mendous co-ordination between the organ procurement organi-
zations and availability of appropriate recipients. More
commonly, the decision to downsize lungs is made intraopera-
tively after both lungs are received by the recipient centre.
Nevertheless, knowing that CLLT is a viable option makes it
easier to accept lungs from larger donors for small-statured reci-
pients with higher acuity.
Unfortunately, due to the relative urgency of transplant, recipi-
ents deemed candidates of CLLT may be at higher risk and have
more haemodynamic instability during the reperfusion phase.
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